CARDLYTICS, INC. (CDLX)
Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Extreme Networks Announces Investor Conferences for May and June 2026
Contineum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
InspireMD Announces FDA Approval of Investigational Device Exemption Application for CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System
Summary Notice of Proposed Settlement of Derivative Action
TransAct Technologies to Report First Quarter 2026 Results On May 12, 2026, Host Conference Call and Webcast
Upland Announces Commencement of New CEO Tenure and Inducement Awards
Taitron Announces Quarterly Cash Dividend
GigCapital7 Corp. Announces Non-Redemption Agreements Funding in the Approximate Amount of at Least $19.3 Million in Conjunction with the Anticipated Closing of the Business Combination with Hadron Energy, Inc.
InspireMD Initiates Voluntary U.S. Recall of CGuard® Prime 135 cm Carotid Stent Delivery System
Heidmar Announces Filing of Its 2025 Annual Report on Form 20-F
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Dave & Buster’s Announces Board of Directors Transition